Search results for "Chronic kidney disease"


 
Results 21 - 30 of about 165 for "Chronic kidney disease".
Sort by: Relevance | Newest | Oldest

New recommendations advise on adding SGLT-2 inhibitors and GLP-1 receptor agonists

A new guideline from The BMJ strongly recommends sodium-glucose cotransporter-2 (SGLT-2) inhibitors for patients with diabetes and established cardiovascular and chronic kidney disease, among other advice.
https://immattersacp.org/weekly/archives/2021/05/18/4.htm
18 May 2021

MKSAP Quiz: 1-year history of lower extremity edema

This week's quiz asks readers to determine the most likely diagnosis for a 60-year-old man with a 30-year history of poorly controlled ankylosing spondylitis and intermittent uveitis who is evaluated for a 1-year history of lower extremity edema.
https://immattersacp.org/weekly/archives/2023/02/14/3.htm
14 Feb 2023

NKF-ASN task force issues final report on use of race in diagnosing kidney disease

Effective immediately in the U.S., estimated glomerular filtration rate should be calculated with an updated equation that does not include a race modifier for Black patients, the National Kidney Foundation (NKF) and the American Society of Nephrology (ASN) said.
https://immattersacp.org/weekly/archives/2021/09/28/2.htm
28 Sep 2021

MKSAP Quiz: Follow-up for microscopic hematuria

A 35-year-old woman is evaluated during a follow-up visit for recurrent microscopic hematuria without proteinuria. Following a physical exam, lab studies, and kidney ultrasound, what is the most likely diagnosis?
https://immattersacp.org/weekly/archives/2022/03/08/3.htm
8 Mar 2022

MKSAP Quiz: Follow-up for diabetes, hyperlipidemia, hypertension

A 68-year-old man is evaluated during a routine follow-up visit. Medical history is significant for type 2 diabetes mellitus, hyperlipidemia, hypertension, and aortofemoral bypass surgery 2 years ago. Following a physical exam, what is the most appropriate additional treatment?
https://immattersacp.org/weekly/archives/2022/11/15/3.htm
15 Nov 2022

Race-adjusted eGFR may negatively affect CKD care in African American patients

A cross-sectional registry study found that one-third of African American patients with chronic kidney disease (CKD) would hypothetically be reclassified to a more severe stage if the race multiplier were removed from a common estimated glomerular filtration rate (eGFR) equation.
https://immattersacp.org/weekly/archives/2020/10/27/4.htm
27 Oct 2020

Equation for kidney failure risk that excludes race shows better sensitivity, specificity than eGFR alone

The four-variable equation includes age, sex, estimated glomerular filtration rate (eGFR), and urinary albumin-creatinine ratio.
https://immattersacp.org/weekly/archives/2022/01/11/4.htm
11 Jan 2022

Guideline recommends allopurinol as first-line therapy for gout

The American College of Rheumatology noted that the drug is the preferred choice for urate-lowering therapy in all patients, including those with moderate to severe chronic kidney disease.
https://immattersacp.org/weekly/archives/2020/05/19/4.htm
19 May 2020

Allopurinol not associated with increased mortality in patients with CKD, gout

The findings of a database analysis from the United Kingdom provide reassurance that a treat-to-target strategy has no apparent harmful effect on mortality in patients with gout and chronic kidney disease (CKD).
https://immattersacp.org/weekly/archives/2022/01/25/2.htm
25 Jan 2022

ADA updates diabetes standards of care for 2023

The American Diabetes Association (ADA) has changed its recommendations on hypertension cutoffs, use of statins, and treatment of patients with diabetes and chronic kidney disease, among other topics.
https://immattersacp.org/weekly/archives/2022/12/20/1.htm
20 Dec 2022

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next